Spots Global Cancer Trial Database for vinblastine
Every month we try and update this database with for vinblastine cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Fitness-adapted, Pembrolizumab-based Therapy for Untreated Classical Hodgkin Lymphoma Patients 60 Years of Age and Above | NCT05404945 | Classical Hodgk... | Pembrolizumab Doxorubicin Vinblastine Dacarbazine Brentuximab ved... | 60 Years - | University of Virginia | |
| A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma | NCT01060904 | Disease, Hodgki... | brentuximab ved... doxorubicin vinblastine dacarbazine bleomycin brentuximab ved... | 18 Years - 60 Years | Seagen Inc. | |
| R-CHOP Versus R-mini-CEOP in Elderly Patients(>65)With DLBCL | NCT01148446 | Elderly Patient... Diffuse Large B... | Cyclophosphamid... Cyclophosphamid... Doxorubicin Vincristine Prednisone Prednisone Epirubicin Vinblastine Rituximab G-CSF | 66 Years - 80 Years | Fondazione Italiana Linfomi - ETS | |
| Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy | NCT05180825 | Grade 1 Glioma Mixed Glio-neur... Pleomorphic Xan... | Trametinib Vinblastine | 1 Month - 25 Years | University Hospital, Strasbourg, France | |
| A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma | NCT02979522 | Hodgkin Disease | Brentuximab ved... Doxorubicin Vinblastine Dacarbazine | 5 Years - 17 Years | Takeda | |
| A Phase II Multicenter Study of Chemotherapy Versus Chemotherapy Plus Durvalumab (MEDI 4736) in Patients With Lymph Node Positive Urothelial Carcinoma of the Bladder | NCT05137262 | Urothelial Carc... Bladder Cancer | Abiraterone ace... Durvalumab Methotrexate Vinblastine Doxorubicin Hyd... Cisplatin | 18 Years - | M.D. Anderson Cancer Center | |
| Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease | NCT01404936 | Lymphoma | Interferon-2A Adriamycin Bleomycin Velban Dacarbazine | - | M.D. Anderson Cancer Center | |
| Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting | NCT00412425 | Melanoma | Palonosetron | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma | NCT00512980 | Hodgkin Lymphom... | prednisone vinblastine doxorubicin gemcitabine | 18 Years - 60 Years | University of Cologne | |
| Chemotherapy Before Surgery in Treating Patients With High Grade Upper Urinary Tract Cancer | NCT02412670 | High Grade Uppe... | Methotrexate Vinblastine Doxorubicin Cisplatin Gemcitabine Carboplatin Pegfilgrastim Nephroureterect... | 18 Years - | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma | NCT00086801 | Lymphoma | doxorubicin hyd... gemcitabine hyd... vinblastine fludeoxyglucose... CT scan | 16 Years - | Alliance for Clinical Trials in Oncology | |
| A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 | NCT03058289 | Breast Cancer Head and Neck C... Squamous Cell C... Lymphoma Pancreatic Canc... Liver Cancer Colon Cancer Lung Cancer Bile Duct Cance... Chordoma of Sac... Sarcoma | INT230-6 anti-PD-1 antib... anti-CTLA-4 ant... | 18 Years - | Intensity Therapeutics, Inc. | |
| Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease | NCT01404936 | Lymphoma | Interferon-2A Adriamycin Bleomycin Velban Dacarbazine | - | M.D. Anderson Cancer Center | |
| Prospective Study on HIV-related Hodgkin Lymphoma | NCT01468740 | HIV-associated ... | Doxorubicin Bleomycin Vinblastine Dacarbazine Etoposide Cyclophosphamid... Vincristine Procarbazine Prednisone | 18 Years - 75 Years | Harlachinger Krebshilfe e.V. | |
| Study of Prednisone, Vinblastine, Doxorubicin, and Gemcitabine in Elderly Patients With Advanced Stages Hodgkin's Lymphoma | NCT00147875 | Hodgkin's Disea... | Prednisone Vinblastine Doxorubicin (Ad... Gemcitabine | 60 Years - 75 Years | University of Cologne | |
| Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational) | NCT02181738 | Hodgkin Disease | Nivolumab Doxorubicin Vinblastine Dacarbazine | 18 Years - | Bristol-Myers Squibb | |
| Brentuximab Vedotin and Nivolumab in Treating Patients With Early Stage Classic Hodgkin Lymphoma | NCT03712202 | Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Classic Hodgkin... Lymphocyte-Rich... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... | Bleomycin Brentuximab Ved... Dacarbazine Doxorubicin Nivolumab Quality-of-Life... Vinblastine | 16 Years - | City of Hope Medical Center | |
| Therapy for Pediatric Relapsed or Refractory Precursor B-Cell Acute Lymphoblastic Leukemia and Lymphoma | NCT01700946 | Recurrent B-Cel... Recurrent Child... | dexamethasone vincristine sul... rituximab clofarabine cyclophosphamid... etoposide aldesleukin pegaspargase methotrexate mercaptopurine cytarabine mitoxantrone teniposide vinblastine natural killer ... laboratory biom... therapeutic hyd... allogeneic hema... CliniMACS | - 21 Years | St. Jude Children's Research Hospital | |
| A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma | NCT02979522 | Hodgkin Disease | Brentuximab ved... Doxorubicin Vinblastine Dacarbazine | 5 Years - 17 Years | Takeda | |
| HD10 for Early Stages | NCT00265018 | Hodgkin´s Lymph... | Adriamycin Bleomycin Vinblastine DTIC 30 Gy IF-RT 20 Gy IF-RT | 16 Years - 75 Years | University of Cologne | |
| Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational) | NCT02181738 | Hodgkin Disease | Nivolumab Doxorubicin Vinblastine Dacarbazine | 18 Years - | Bristol-Myers Squibb | |
| Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma | NCT01771107 | AIDS-Related Ho... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Classic Hodgkin... HIV Infection | Brentuximab Ved... Dacarbazine Doxorubicin Hyd... Pharmacological... Vinblastine | 18 Years - | National Cancer Institute (NCI) | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | NCT00003389 | Lymphoma | Doxorubicin Bleomycin Vinblastine Dacarbazine Vincristine Mechlorethamine Etoposide Prednisone Cyclophosphamid... Radiotherapy | 16 Years - | Eastern Cooperative Oncology Group | |
| S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer | NCT02177695 | Bladder Cancer | Gemcitabine Cisplatin Methotrexate Vinblastine Doxorubicin Filgrastim | 18 Years - | SWOG Cancer Research Network | |
| Study Comparing ABVD vs BEACOPP in Advanced Hodgkin's Lymphoma | NCT01251107 | Hodgkin Lymphom... | Bleomycin Etoposide Doxorubicin Cyclophosphamid... Vincristine Procarbazine Prednisone Doxorubicin Bleomycin Vinblastine Dacarbazine | 17 Years - 60 Years | Fondazione Michelangelo | |
| Phase 2 Study of Rituximab-ABVD in Classical Hodgkin Lymphoma | NCT00369681 | Lymphoma | Bleomycin Rituximab Dacarbazine Doxorubicin Vinblastine | 18 Years - 120 Years | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | |
| Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma | NCT00808639 | Bladder Cancer Muscle-invasive... | Methotrexate Doxorubicin vinblastine cisplatin Pegfilgrastim | 18 Years - | Dana-Farber Cancer Institute | |
| Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults | NCT01884922 | Refractory Low-... Recurrent Low-g... | Nilotinib Vinblastine | 6 Months - 20 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| Doxorubicin, Vinblastine, Dacarbazine, Brentuximab Vedotin, and Nivolumab in Treating Patients With Stage I-II Hodgkin Lymphoma | NCT03233347 | Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Ann Arbor Stage... Classic Hodgkin... | Brentuximab Ved... Dacarbazine Doxorubicin Laboratory Biom... Nivolumab Vinblastine | 18 Years - 60 Years | Academic and Community Cancer Research United | |
| SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease | NCT00002495 | Lymphoma | doxorubicin hyd... vinblastine standard subtot... | 16 Years - | SWOG Cancer Research Network | |
| Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study | NCT03517137 | Advanced Hodgki... | Brentuximab Ved... Adriamycin Vinblastine Dacarbazine Etoposide Cyclophosphamid... Radiation Thera... | 18 Years - 60 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium | NCT00003376 | Bladder Cancer Transitional Ce... Urethral Cancer | carboplatin cisplatin doxorubicin hyd... methotrexate paclitaxel vinblastine | 18 Years - 120 Years | Eastern Cooperative Oncology Group | |
| SWOG-9133 RT w/ or w/o Doxorubicin and Vinblastine in Stage I or Stage II Hodgkin's Disease | NCT00002495 | Lymphoma | doxorubicin hyd... vinblastine standard subtot... | 16 Years - | SWOG Cancer Research Network | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| Study of Vinblastine in Combination With Nilotinib in Children, Adolescents, and Young Adults | NCT01887522 | Refractory Low-... Recurrent Low-g... | Vinblastine + N... Vinblastine | 6 Months - 20 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer. | NCT00520403 | Renal Cell Canc... | bevacizumab [Av... Interferon alfa... Vinblastine | 18 Years - | Hoffmann-La Roche | |
| Study of Nivolumab in Patients With Classical Hodgkin's Lymphoma (Registrational) | NCT02181738 | Hodgkin Disease | Nivolumab Doxorubicin Vinblastine Dacarbazine | 18 Years - | Bristol-Myers Squibb | |
| Combination Chemotherapy With or Without Rituximab in Treating Participants With Stage III-IV Classic Hodgkin Lymphoma | NCT00654732 | Classic Hodgkin... Lugano Classifi... Lugano Classifi... | Bleomycin Dacarbazine Doxorubicin Hyd... Rituximab Vinblastine | 17 Years - | M.D. Anderson Cancer Center | |
| Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer | NCT00024167 | Prostate Cancer | Docetaxel Doxorubicin hyd... Estramustine ph... Ketoconazole Prednisone Vinblastine Strontium chlor... Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy | NCT05180825 | Grade 1 Glioma Mixed Glio-neur... Pleomorphic Xan... | Trametinib Vinblastine | 1 Month - 25 Years | University Hospital, Strasbourg, France | |
| Combination Chemotherapy in Treating Patients With Neurofibromatosis and Progressive Plexiform Neurofibromas | NCT00030264 | Neurofibromatos... Precancerous Co... | Methotrexate Vinblastine | - 25 Years | Children's Hospital of Philadelphia | |
| Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults | NCT01884922 | Refractory Low-... Recurrent Low-g... | Nilotinib Vinblastine | 6 Months - 20 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma | NCT06164275 | Classic Hodgkin... | Biopsy Biospecimen Col... Computed Tomogr... Dacarbazine Doxorubicin Echocardiograph... Multigated Acqu... Pembrolizumab Positron Emissi... Vinblastine | 18 Years - | Northwestern University | |
| Methotrexate, Vinblastine, Doxorubicin and Cisplatin (MVAC) Followed by Gemcitabine Plus Cisplatin (GEM+CDDP) in Locally Advanced or Metastatic Bladder Cancer | NCT00635726 | Bladder Cancer | Methotrexate Vinblastine Doxorubicin Cisplatin Cisplatin Gemcitabine | 18 Years - 75 Years | Hellenic Oncology Research Group | |
| Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma | NCT06164275 | Classic Hodgkin... | Biopsy Biospecimen Col... Computed Tomogr... Dacarbazine Doxorubicin Echocardiograph... Multigated Acqu... Pembrolizumab Positron Emissi... Vinblastine | 18 Years - | Northwestern University | |
| Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting | NCT00412425 | Melanoma | Palonosetron | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma | NCT01712490 | Hodgkin Lymphom... | brentuximab ved... doxorubicin bleomycin vinblastine dacarbazine | 18 Years - | Takeda | |
| A Study of Brentuximab Vedotin + Adriamycin, Vinblastine, and Dacarbazine in Pediatric Participants With Advanced Stage Newly Diagnosed Hodgkin Lymphoma | NCT02979522 | Hodgkin Disease | Brentuximab ved... Doxorubicin Vinblastine Dacarbazine | 5 Years - 17 Years | Takeda | |
| A Phase I Study of Continuous Intravenous Infusion of PSC 833 and Vinblastine in Patients With Metastatic Renal Cancer | NCT00001570 | Kidney Neoplasm... Neoplasm Metast... | PSC 833 vinblastine | - | National Institutes of Health Clinical Center (CC) | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs) | NCT00575796 | Glioma | Vinblastine Sul... | 1 Year - 18 Years | The Hospital for Sick Children | |
| A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma | NCT01060904 | Disease, Hodgki... | brentuximab ved... doxorubicin vinblastine dacarbazine bleomycin brentuximab ved... | 18 Years - 60 Years | Seagen Inc. | |
| S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer | NCT02177695 | Bladder Cancer | Gemcitabine Cisplatin Methotrexate Vinblastine Doxorubicin Filgrastim | 18 Years - | SWOG Cancer Research Network | |
| Study of Safety and Efficacy of Pembrolizumab and Chemotherapy in Participants With Newly Diagnosed Classical Hodgkin Lymphoma (cHL) (MK-3475-C11/KEYNOTE-C11) | NCT05008224 | Classical Hodgk... | Pembrolizumab Doxorubicin Vinblastine Dacarbazine Bleomycin Etoposide Cyclophosphamid... Vincristine Procarbazine Prednisone | 18 Years - | Merck Sharp & Dohme LLC | |
| Vinblastine +/- Bevacizumab in Children With Unresectable or Progressive Low Grade Glioma (LGG) | NCT02840409 | Low Grade Gliom... | Vinblastine Bevacizumab | 6 Months - 18 Years | The Hospital for Sick Children | |
| Weekly Vinblastine for Chemotherapy Naive Children With Progressive Low Grade Glioma (PLGGs) | NCT00575796 | Glioma | Vinblastine Sul... | 1 Year - 18 Years | The Hospital for Sick Children | |
| A Phase 1 Study of Brentuximab Vedotin Combined With Multi-Agent Chemotherapy for Hodgkin Lymphoma | NCT01060904 | Disease, Hodgki... | brentuximab ved... doxorubicin vinblastine dacarbazine bleomycin brentuximab ved... | 18 Years - 60 Years | Seagen Inc. | |
| Dose-Dense MVAC With Pegfilgrastim Support in Subjects With Muscle-Invasive Urothelial Carcinoma | NCT00808639 | Bladder Cancer Muscle-invasive... | Methotrexate Doxorubicin vinblastine cisplatin Pegfilgrastim | 18 Years - | Dana-Farber Cancer Institute | |
| Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage I or Stage II Hodgkin's Lymphoma | NCT00086801 | Lymphoma | doxorubicin hyd... gemcitabine hyd... vinblastine fludeoxyglucose... CT scan | 16 Years - | Alliance for Clinical Trials in Oncology | |
| Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer | NCT00024167 | Prostate Cancer | Docetaxel Doxorubicin hyd... Estramustine ph... Ketoconazole Prednisone Vinblastine Strontium chlor... Dexamethasone | 18 Years - | M.D. Anderson Cancer Center | |
| Study Of Vinblastine in Combination With Nilotinib in Children, Adolescents and Young Adults | NCT01884922 | Refractory Low-... Recurrent Low-g... | Nilotinib Vinblastine | 6 Months - 20 Years | Gustave Roussy, Cancer Campus, Grand Paris | |
| Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma | NCT00003389 | Lymphoma | Doxorubicin Bleomycin Vinblastine Dacarbazine Vincristine Mechlorethamine Etoposide Prednisone Cyclophosphamid... Radiotherapy | 16 Years - | Eastern Cooperative Oncology Group | |
| Combination Chemotherapy +/- Radiation in High Risk Hodgkin's Disease | NCT00225173 | Hodgkin Disease | Doxorubicin Vinblastine Cyclophosphamid... Etoposide Vincristine Bleomycin Gemcitabine Vinorelbine Prednisone | 18 Years - 70 Years | Stanford University | |
| Brentuximab Vedotin and Combination Chemotherapy in Treating Older Patients With Previously Untreated Stage II-IV Hodgkin Lymphoma | NCT01476410 | Adult Lymphocyt... Adult Lymphocyt... Adult Mixed Cel... Adult Nodular S... Stage II Adult ... Stage III Adult... Stage IV Adult ... | brentuximab ved... doxorubicin hyd... vinblastine dacarbazine quality-of-life... DNA analysis RNA analysis fludeoxyglucose... positron emissi... laboratory biom... immunohistochem... polymorphism an... | 60 Years - | Northwestern University | |
| Pediatric Low Grade Glioma - MEKinhibitor TRIal vs Chemotherapy | NCT05180825 | Grade 1 Glioma Mixed Glio-neur... Pleomorphic Xan... | Trametinib Vinblastine | 1 Month - 25 Years | University Hospital, Strasbourg, France | |
| Biochemotherapy With Temozolomide for Metastatic Melanoma | NCT00505635 | Melanoma | Temozolomide Velban Cisplatin Interleukin-2 Intron-A Thalidomide | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Pembrolizumab Followed by Chemotherapy for the Treatment of Patients With Classical Hodgkin Lymphoma | NCT06164275 | Classic Hodgkin... | Biopsy Biospecimen Col... Computed Tomogr... Dacarbazine Doxorubicin Echocardiograph... Multigated Acqu... Pembrolizumab Positron Emissi... Vinblastine | 18 Years - | Northwestern University | |
| A Study of Avastin (Bevacizumab) in Combination With Standard Therapy in Patients With Metastatic Renal Cell Cancer. | NCT00520403 | Renal Cell Canc... | bevacizumab [Av... Interferon alfa... Vinblastine | 18 Years - | Hoffmann-La Roche | |
| A Phase 1/2 Safety Study of Intratumorally Dosed INT230-6 | NCT03058289 | Breast Cancer Head and Neck C... Squamous Cell C... Lymphoma Pancreatic Canc... Liver Cancer Colon Cancer Lung Cancer Bile Duct Cance... Chordoma of Sac... Sarcoma | INT230-6 anti-PD-1 antib... anti-CTLA-4 ant... | 18 Years - | Intensity Therapeutics, Inc. | |
| FIL Study on ABVD DD-DI as Upfront Therapy in HL. | NCT03159897 | Hodgkin Lymphom... | Doxorubicin Bleomycin Vinblastine Dacarbazine | 18 Years - 60 Years | Fondazione Italiana Linfomi - ETS | |
| Prospective Study on HIV-related Hodgkin Lymphoma | NCT01468740 | HIV-associated ... | Doxorubicin Bleomycin Vinblastine Dacarbazine Etoposide Cyclophosphamid... Vincristine Procarbazine Prednisone | 18 Years - 75 Years | Harlachinger Krebshilfe e.V. | |
| Combination Chemotherapy With Ketoconazole in Treating Patients With Prostate Cancer | NCT00003084 | Prostate Cancer | Doxorubicin Hyd... Estramustine ph... Etoposide Ketoconazole Paclitaxel Vinblastine | 18 Years - | M.D. Anderson Cancer Center | |
| Doxorubicin Hydrochloride, Pembrolizumab, Vinblastine, and Dacarbazine in Treating Patients With Classical Hodgkin Lymphoma | NCT03331341 | Classical Hodgk... | Dacarbazine Doxorubicin Hyd... Laboratory Biom... Pembrolizumab Vinblastine | 18 Years - | University of Washington | |
| Nivolumab in Combination With Metronomic Chemotherapy in Paediatrics Refractory / Relapsing Solid Tumors | NCT03585465 | Childhood Solid... | Vinblastine Cyclophosphamid... Capecitabine Nivolumab | 0 Years - 18 Years | Centre Oscar Lambret | |
| Palonosetron for Prevention of Biochemotherapy Induced Nausea and Vomiting | NCT00412425 | Melanoma | Palonosetron | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Vinblastine and Temsirolimus in Pediatrics With Recurrent or Refractory Lymphoma or Solid Tumours Including CNS Tumours | NCT02343718 | Recurrent Lymph... Refractory Lymp... Solid Tumours Central Nervous... | Vinblastine Temsirolimus | 1 Year - 18 Years | Canadian Cancer Trials Group | |
| S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma | NCT00006237 | Melanoma (Skin) | interleukin-2 filgrastim interferon alfa cisplatin dacarbazine vinblastine | 18 Years - | SWOG Cancer Research Network | |
| PVAG-14 Pilot for Intermediate Stages Hodgkin Lymphoma | NCT00512980 | Hodgkin Lymphom... | prednisone vinblastine doxorubicin gemcitabine | 18 Years - 60 Years | University of Cologne | |
| A Frontline Therapy Trial in Participants With Advanced Classical Hodgkin Lymphoma | NCT01712490 | Hodgkin Lymphom... | brentuximab ved... doxorubicin bleomycin vinblastine dacarbazine | 18 Years - | Takeda |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
